OGN:NYSE
Organon & Co
USD 13,92
arrow_upward
+0,14%(+0,020) 1D
USD 13,86
arrow_downward
-0,46% (-0,064)bedtimeAfter hours
Closed: 18 Nov., 16:00:04 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OGN...
Open
USD 13,89
High
USD 13,92
Low
USD 13,88
Mkt. cap
3,66 mjd
Avg. vol.
2,62 m
Volume
3,90 m
Dividend
0,57%
Quarterly dividend
USD 0,02
Ex-dividend date
14 Aug. 2026
P/E ratio
18,10
52-wk high
USD 13,92
52-wk low
USD 5,69
EPS
USD 0,77
Beta
1,53
Shares outstanding
262,62 m
No. of employees
10 k
Open
USD 13,89
High
USD 13,92
Low
USD 13,88
Mkt. cap
3,66 mjd
Avg. vol.
2,62 m
Volume
3,90 m
Dividend
0,57%
Quarterly dividend
USD 0,02
Ex-dividend date
14 Aug. 2026
P/E ratio
18,10
52-wk high
USD 13,92
52-wk low
USD 5,69
EPS
USD 0,77
Beta
1,53
Shares outstanding
262,62 m
No. of employees
10 k
News stories
From web sources and news partners
Yahoo Finance
·
3 uur gelede
Organon & Co. (OGN) Stock Forecasts
Investing.com
·
3 uur gelede
Organon & Co stock hits 52-week high at 13.91 USD
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10 k
Founded1923
HeadquartersJersey City, New Jersey, Verenigde State van Amerika
SectorHealth Care
IndustryPharmaceutical industry
Websiteorganon.com